Cargando…

Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease

Chronic graft-versus host disease (cGVHD) occurs in 30% to 70% of patients undergoing allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of cGVHD patients, causing discomfort, limiting the range of movement, and increasing the risk of wound infections. Furthermore, syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yoo Jung, Lee, Gun Ho, Kwong, Bernice Y, Martires, Kathryn J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977575/ https://www.ncbi.nlm.nih.gov/pubmed/32025391 http://dx.doi.org/10.7759/cureus.6462

Ejemplares similares

MicroRNA serum profiles and chronic graft-versus-host disease
por: Reikvam, Håkon, et al.
Publicado: (2022)

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021)

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival
por: Pidala, Joseph, et al.
Publicado: (2021)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
por: Kim, Haesook T., et al.
Publicado: (2022)

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
por: Cuvelier, Geoffrey D. E., et al.
Publicado: (2022)

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017)

Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
por: Martin, Paul J., et al.
Publicado: (2021)

Prediction of outcomes after second-line treatment for acute graft-versus-host disease
por: Vo, Phuong, et al.
Publicado: (2022)

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023)

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022)

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger
por: Azem, Amin, et al.
Publicado: (2022)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
por: Hashmi, Hamza, et al.
Publicado: (2020)

Shoshin beriberi in a patient with oral and cutaneous graft-versus-host disease
por: Hodgkinson, Luqman Mushila, et al.
Publicado: (2020)

Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience
por: Kaufman, Stuart S., et al.
Publicado: (2021)

Clonal expansion of CD8(+) T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
por: Schultze-Florey, Christian R., et al.
Publicado: (2021)

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008)

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
por: Lum, Su Han, et al.
Publicado: (2022)

Alteration in the Skin Microbiome in Cutaneous Graft-Versus-Host Disease
por: GU, Ying, et al.
Publicado: (2021)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Pulmonary Allograft Versus Host Disease
por: Dai, David W., et al.
Publicado: (2017)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Pancreatic Grafts from Pediatric Donors Do Not Appear to Grow After Transplantation into Adults
por: Christensen, Kaerli, et al.
Publicado: (2018)

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure
por: Sabulski, Anthony, et al.
Publicado: (2021)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Local Autoantigen Expression as Essential Gatekeeper of Memory T-Cell Recruitment to Islet Grafts in Diabetic Hosts
por: Alkemade, Gonnie M., et al.
Publicado: (2013)

Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance
por: Chung, Patrick Ho Yu, et al.
Publicado: (2016)

Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature
por: Huart, Justine, et al.
Publicado: (2018)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Chronic Cutaneous Graft versus Host Disease Mimicking Warts
por: Lee, Bo In, et al.
Publicado: (2015)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013)

Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation
por: Hough, Rachael, et al.
Publicado: (2022)

Use of Injectable Platelet-Rich Fibrin Accompanied by Bone Graft in Socket Endurance: A Radiographic and Histological Study
por: Nagrani, Tanya, et al.
Publicado: (2023)

Microbiota and Graft-versus Host disease: a double-edged sword
por: Holler, Ernst, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n27op9nrsigdhlfngah8c69qsd